Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W Johnson

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
JMIR Formative Research|July 25, 2020
Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Message Surveys in African-American Young Adults Experiencing Homelessness and Unemployment: Single-Group StudyLarissa Jennings Mayo-Wilson, Nancy E Glass, Alain Labrique, et al.
Journal of Psychopharmacology (Oxford, England)|September 1, 2016
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequencesTheresa M Carbonaro, Matthew P Bradstreet, Frederick S Barrett, et al.
Journal of Psychopharmacology (Oxford, England)|February 15, 2022
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-upNatalie Gukasyan, Alan K Davis, Frederick S Barrett, et al.
Journal of Psychopharmacology (Oxford, England)|May 31, 2021
Psychedelics and health behaviour changePedro J Teixeira, Matthew W Johnson, Christopher Timmermann, et al.
Journal of Clinical Psychopharmacology|July 21, 2025
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled StudyGuy Ludbrook, Nathan Bryson, Beatrix Taylor, et al.
Military Medicine|December 24, 2022
Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain InjuryJoshua C Gray, Mikela Murphy, Sierra E Carter, et al.
Addiction (Abingdon, England)|June 24, 2017
To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patientsD Andrew Tompkins, Andrew S Huhn, Patrick S Johnson, et al.
Drug and Alcohol Dependence|October 11, 2021
Single- and cross-commodity discounting among adults who use alcohol and cannabis: Associations with tobacco use and clinical indicatorsGideon P Naudé, Derek D Reed, David P Jarmolowicz, et al.
Archives of Sexual Behavior|April 25, 2020
Attention-Deficit/Hyperactivity Disorder Symptoms Are Associated with Greater Delay Discounting of Condom-Protected Sex and MoneyMeredith S Berry, Mary M Sweeney, Sean B Dolan, et al.
Tobacco Prevention & Cessation|May 4, 2026
A descriptive content analysis of greenwashing tactics used in US cigarette advertisements between 2019-2023Maryam Ibrahim, Meghan B Moran, Lauren Czaplicki, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
JMIR Formative Research|July 25, 2020
Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Message Surveys in African-American Young Adults Experiencing Homelessness and Unemployment: Single-Group StudyLarissa Jennings Mayo-Wilson, Nancy E Glass, Alain Labrique, et al.
Journal of Psychopharmacology (Oxford, England)|September 1, 2016
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequencesTheresa M Carbonaro, Matthew P Bradstreet, Frederick S Barrett, et al.
Journal of Psychopharmacology (Oxford, England)|February 15, 2022
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-upNatalie Gukasyan, Alan K Davis, Frederick S Barrett, et al.
Journal of Psychopharmacology (Oxford, England)|May 31, 2021
Psychedelics and health behaviour changePedro J Teixeira, Matthew W Johnson, Christopher Timmermann, et al.
Journal of Clinical Psychopharmacology|July 21, 2025
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled StudyGuy Ludbrook, Nathan Bryson, Beatrix Taylor, et al.
Military Medicine|December 24, 2022
Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain InjuryJoshua C Gray, Mikela Murphy, Sierra E Carter, et al.
Addiction (Abingdon, England)|June 24, 2017
To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patientsD Andrew Tompkins, Andrew S Huhn, Patrick S Johnson, et al.
Drug and Alcohol Dependence|October 11, 2021
Single- and cross-commodity discounting among adults who use alcohol and cannabis: Associations with tobacco use and clinical indicatorsGideon P Naudé, Derek D Reed, David P Jarmolowicz, et al.
Archives of Sexual Behavior|April 25, 2020
Attention-Deficit/Hyperactivity Disorder Symptoms Are Associated with Greater Delay Discounting of Condom-Protected Sex and MoneyMeredith S Berry, Mary M Sweeney, Sean B Dolan, et al.
Tobacco Prevention & Cessation|May 4, 2026
A descriptive content analysis of greenwashing tactics used in US cigarette advertisements between 2019-2023Maryam Ibrahim, Meghan B Moran, Lauren Czaplicki, et al.
Pageof 18